Prognostic effect on overall survival of patients with the different NPM1/FLT3-ITD genotypes categorized according to 2017 ELN genetic risk groups. The P values for the log-rank tests comparing favorable vs intermediate and intermediate vs adverse are P = .007 and P = .20, respectively.